Application for making an initial appointment is handled at the Patient Referrals at the Shizuoka Cancer Center.
The system for patient referrals has been established in order to secure close ties with local medical institutions and to provide local patients with the best cancer medicine. It serves as a window for clinics and medical institutions in the region when they need to make appointments for diagnoses and examinations at the SCC.
When you want to refer your patient to the SCC, please see below for what you should do to make an initial appointment.
Please send a “Letter of Introduction” to the Patient Referrals by fax.
Please refer to the SCC form for “Letter of Introduction” (in Japanese) but it can be in any forms.
Once the appointment is fixed, “Appointment Slip” (in Japanese) will be sent back in reply via fax
Please be sure to tell your patient the day and the time of appointment yourself, as well as to hand him/her the Appointment Slip.
The original copy of the “Letter of Introduction” must be handed to your patient.
Please prepare samples and specimen for your patient and hand them to him/her.
For more information, please contact the Patient Referrals at the SCC.
phone number (for medical institutions only) 055-989-5646
fax number 055-989-5623
open from 8:30 a.m. to 7:00 p.m.
(closed on Saturdays, Sundays & Japanese national holidays)
Study on the efficacy and the safety of proton therapy:
Proton therapy is provided as “Advanced Medicine A” which is a designation included in the “Standardized Therapeutic Strategy” approved by all the proton therapy facilities nationwide. We are making it sure that all the cases are registered and the follow-up examinations are provided periodically, aiming at inclusion in the Japanese national health insurance listing.
Proton therapy has been included in the national health insurance listing since 2016 for pediatric cancer treatment, and it is supposed to be provided based on the application criteria precisely determined by the Cancer Board organized together with the Shizuoka Children’s Hospital. We are ready to provide it for the cases where the efficacy and the safety are projected, collaborating with the Division of Pediatrics.
Murayama S and Fuji H, Proton therapy at Shizuoka Cancer Center, Gan to kagaku ryoho. Cancer & chemotherapy 11/2009; 36(11):1806-12.
Murayama S, Fuji H, et al., Initial clinical experience of proton therapy at Shizuoka Cancer Center, Radiation and Proton Therapy Center, Shizuoka Cancer Center Hospital. Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica 10/2005; 65(4):424-31. Source: PubMed.
Yasui K, Kondou R, Iizuka A, Miyata H, Tanaka E, Ashizawa T, Nagashima T, Ohshima K, Urakami K, Kusuhara M, Muramatsu K, Sugino T, Yamguchi K, Mori K, Harada H, Nishimura T, Kagawa H, Yamakawa Y, Hino H, Shiomi A, Akiyama Y. Effect of preoperative chemoradiotherapy on the immunological status of rectal cancer patients. J Radiat Res. 2020.
Tomida T, Konno M, Urikura A, Yoshida T, Yasui K, Hanmura M. Wedged field using the half-field method with a flattening filter-free photon beam. Radiol Phys Technol. 2020;13:201-9.
Muramatsu N, Ito S, Hanmura M, Nishimura T. Development of a transparent and flexible patient-specific bolus for total scalp irradiation. Radiol Phys Technol. 2021;14:82-92.
Harada H, Shikama N, Wada H, Uchida N, Nozaki M, Hayakawa K, Yamada K, Nagakura H, Ogawa H, Miyazawa K, Katagiri H, Nakamura N. A phase II study of palliative radiotherapy combined with zoledronic acid hydrate for metastatic bone tumour from renal cell carcinoma. Jpn J Clin Oncol. 2021;51:100-5
